Industry News
Pharmaceutical Industry News
Opioid Makers Win Major Victory in California Trial
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the companies were liable in the epidemic.
Pfizer ups 2021 COVID-19 vaccine sales once again, but it remains coy about future sales
Pfizer ups 2021 COVID-19 vaccine sales once again, but it remains coy about future sales kdunleavy Tue, 11/02/2021 - 12:18
AbbVie’s Vuity snags FDA approval as first eye drop for presbyopia, with rival Eyenovia closely behind
AbbVie’s Vuity snags FDA approval as first eye drop for presbyopia, with rival Eyenovia closely behind aliu Tue, 11/02/2021 - 11:42
AbbVie’s Vuity snags FDA approval as first eye drop for presbyopia, with rival Eyenovia close behind
AbbVie's Vuity snags FDA approval as first eye drop for presbyopia, with rival Eyenovia close behind aliu Tue, 11/02/2021 - 11:42
Incyte combats insurance hurdles for eczema cream Opzelura, but dermatologists fully on board: exec
Incyte combats insurance hurdles for eczema cream Opzelura, but dermatologists fully on board: exec aliu Tue, 11/02/2021 - 10:08
Johnson & Johnson, AbbVie, Teva and Endo score industry’s first opioid trial win
Johnson & Johnson, AbbVie, Teva and Endo score industry's first opioid trial win esagonowsky Tue, 11/02/2021 - 09:56
Once sidelined, Eli Lilly’s COVID-19 antibody treatment is on the comeback trail with new $1.3B supply agreement
Once sidelined, Eli Lilly's COVID-19 antibody treatment is on the comeback trail with new $1.3B supply agreement kdunleavy Tue, 11/02/2021 - 09:43
Lonza snaps up Codiak’s exosome manufacturing site for $65M of ‘in kind’ services
Lonza snaps up Codiak's exosome manufacturing site for $65M of 'in kind' services jkeenan Tue, 11/02/2021 - 09:25
In the CDMO industry’s expansion blitz, Samsung Biologics goes full speed ahead with ‘Super Plant,’ plans to grow global footprint
In the CDMO industry's expansion blitz, Samsung Biologics goes full speed ahead with 'Super Plant,' plans to grow global footprint kdunleavy Tue, 11/02/2021 - 08:08
GenScript embraces automation at its first cell, gene therapy manufacturing US site
GenScript embraces automation at its first cell, gene therapy manufacturing US site jkeenan Tue, 11/02/2021 - 07:56
Meissa posts early clinical data on nasal COVID-19 vaccine, providing support for role in breaking transmission chains
Meissa posts early clinical data on nasal COVID-19 vaccine, providing support for role in breaking transmission chains ntaylor Tue, 11/02/2021 - 05:20
Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Vote
Senator Joe Manchin III of West Virginia, a crucial Democratic swing vote, demanded more time to evaluate the economic and fiscal impact of the $1.85 trillion bill.
Stallergenes, seeking an edge in a competitive space, taps Aptar for connected drug delivery project
Stallergenes, seeking an edge in a competitive space, taps Aptar for connected drug delivery project ntaylor Mon, 11/01/2021 - 12:23
AbbVie’s Parkinson’s pump hits goal in phase 3, setting stage for approval filings
AbbVie’s Parkinson’s pump hits goal in phase 3, setting stage for approval filings ntaylor Mon, 11/01/2021 - 12:20
AstraZeneca resumes asset sale in $270M COPD deal with familiar buyer Covis
AstraZeneca resumes asset sale in $270M COPD deal with familiar buyer Covis aliu Mon, 11/01/2021 - 11:19
Jaguar to pump $125M into North Carolina gene therapy manufacturing facility
Jaguar to pump $125M into North Carolina gene therapy manufacturing facility jkeenan Mon, 11/01/2021 - 10:20
Amid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal litigation for $800M
Amid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal litigation for $800M kdunleavy Mon, 11/01/2021 - 10:08
Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators’ review time only one benefit
Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators' review time only one benefit aliu Mon, 11/01/2021 - 09:42
Novartis keeps the leukemia innovation coming with FDA approval for Gleevec follow-on Scemblix as Tasigna patent cliff nears
Novartis keeps the leukemia innovation coming with FDA approval for Gleevec follow-on Scemblix as Tasigna patent cliff nears aliu Mon, 11/01/2021 - 07:03
Pressure Grows on G20 Nations to Get Covid Vaccines to the Poor
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current one.